Abstract 12594: Pharmacodynamic Effect of ARO-APOC3, an Investigational Hepatocyte-targeted RNA Interference Therapeutic Targeting Apolipoprotein C3, in Patients With Hypertriglyceridemia and Multifactorial Chylomicronemia
暂无分享,去创建一个
S. Melquist | J. Knowles | D. Gaudet | P. Clifton | G. Watts | R. Hegele | C. Ballantyne | I. Goldberg | D. Sullivan | B. Given | C. Schwabe | R. Scott | S. Thackwray | J. Hamilton | Ting Chang | J. Baker | J. Martin | N. Rajicic